Clinical trials: Central Serous Retinopathy (CSR)
Central Serous Retinopathy (CSR), Sub-Threshold Laser
Treatment of Recurrent and Multifocal Central Serous Chorioretinopathy
The goal of this clinical trial is to learn if subthreshold micropulse laser is a safe, effective, and painless treatment for multifocal and recurrent central serous chorioretinopathy (CSCR) in adults.
- Trial name
- NCT07889518
- Testing
- 577 nm Subthreshold Micropulse Laser
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Benha University
Central Serous Chorioretinopathy, Age Related Macular Degeneration
PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept
The presence of PEDs in nAMD, CSR and iPCV can present a diagnostic challenge in the elderly population; despite detailed diagnostic testing to differentiate these three conditions, misdiagnosis and mistreatment still occurs.
- Conditions
- Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy
- Trial name
- PRaCTICAL (NCT02681783)
- Testing
- aflibercept
- Where
- Canada
- Volunteers
- 90 people
- Sponsor
- Sunnybrook Health Sciences Centre
Central Serous Chorioretinopathy
The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
A preliminary study to determine the safety and efficacy of intravitreal aflibercept injection in patients with persistent central serous chorioretinopathy.
- Trial name
- CONTAIN (NCT01710332)
- Testing
- Intravitreal Aflibercept Injection
- Where
- 2 sites in United States
- Volunteers
- 12 people
- Sponsor
- Wills Eye
Central Serous Chorioretinopathy
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
This is a prospective, multicentre, sham-controlled, participant- and assessor-masked superiority trial with two parallel treatment arms which aims to investigate the safety and efficacy of subthreshold nanosecond laser (SNL) in…
- Trial name
- NANO-C (NCT05570591)
- Testing
- 2RT subthreshold nanosecond laser - active
- Where
- 2 sites in Australia
- Volunteers
- 60 people
- Sponsor
- Nova Eye Medical Pty Ltd.
Central Serous Chorioretinopathy
Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)
Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in the pathogenesis of ICSCR so…
- Trial name
- ICSCR (NCT00817245)
- Testing
- omeprazole, Amoxicillin, metronidazole
- Where
- Iran
- Volunteers
- 50 people
- Sponsor
- Tabriz University
Central Serous Retinopathy (CSR)
Eye Patch Therapy for Central Serous Retinopathy (CSR)
First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic…
- Trial name
- NCT02036632
- Testing
- Eye Patching
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Washington University School of Medicine
Central Serous Chorioretinopathy
Eplerenone for the Treatment of Central Serous Chorioretinopathy
To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .
- Trial name
- NCT01990677
- Testing
- 25mg Eplerenone
- Where
- 10 sites in United States
- Volunteers
- 108 people
- Sponsor
- Wills Eye